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A chemical specialty semantic network for the
Unified Medical Language System
C Paul Morrey1*, Yehoshua Perl2, Michael Halper3, Ling Chen4 and Huanying “Helen” Gu5
Abstract
Background: Terms representing chemical concepts found the Unified Medical Language System (UMLS) are used
to derive an expanded semantic network with mutually exclusive semantic types. The UMLS Semantic Network (SN)
is composed of a collection of broad categories called semantic types (STs) that are assigned to concepts. Within
the UMLS’s coverage of the chemical domain, we find a great deal of concepts being assigned more than one ST.
This leads to the situation where the extent of a given ST may contain concepts elaborating variegated semantics.
A methodology for expanding the chemical subhierarchy of the SN into a finer-grained categorization of mutually
exclusive types with semantically uniform extents is presented. We call this network a Chemical Specialty Semantic
Network (CSSN). A CSSN is derived automatically from the existing chemical STs and their assignments. The
methodology incorporates a threshold value governing the minimum size of a type’s extent needed for inclusion in
the CSSN. Thus, different CSSNs can be created by choosing different threshold values based on varying
requirements.
Results: A complete CSSN is derived using a threshold value of 300 and having 68 STs. It is used effectively to
provide high-level categorizations for a random sample of compounds from the “Chemical Entities of Biological
Interest” (ChEBI) ontology. The effect on the size of the CSSN using various threshold parameter values between
one and 500 is shown.
Conclusions: The methodology has several potential applications, including its use to derive a pre-coordinated
guide for ST assignments to new UMLS chemical concepts, as a tool for auditing existing concepts, interterminology mapping, and to serve as an upper-level network for ChEBI.
Keywords: Unified Medical Language System, Vocabulary, Controlled, Semantics, Models, Chemical, Chemical
characterization, Chemical Entities of Biological Interest, Semantic Network

Background
The Semantic Network (SNa) [1-5] of the UMLS
2009AA (used for this research) [6-12] is composed of
135 broad categories called semantic types (STs) that
overlay the nearly 2.1 million concepts of the Metathesaurus (META) [13-16]. A remarkable fact is that since
the first version of the SN only five new STs have been
added, while at the same time the number of concepts
in the META—which are categorized by the STs— has
grown by two orders of magnitude from about 64,000
concepts to 2.1 million concepts. Indeed, in [4], it was
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stated that expanding the SN’s depth of coverage was
part of future plans. One can understand the need not
to let the SN grow too expansive and lose its impact as a
compact abstraction network. In the interim, we have
seen proposals for additional STs, such as those for the
coverage of genomics [17-19] and refinement and
expansion in other areas [20]. There have also been
suggestions about changing the structure of the SN
from a tree to a directed acyclic graph [21-24]. In a
workshop “The Future of the UMLS Semantic Network”
(see http://mor.nlm.nih.gov/snw) organized by the NLM
in 2005, various potential changes were discussed.
However, no change occurred until the 2010AA release (see http://download.nlm.nih.gov/umls/kss/2010A
A/README.txt) which removed three STs (Invertebrateb
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Rickettsia or Chlamydia, and Alga) and added one new
one (Eukaryote).
An abstraction network, such as the SN, can be a useful
aid in regards to the issues of comprehension, integration,
and navigation of a large terminological system. It affords
a view of the underlying concept repository that is compact yet gives an idea of the gestalt of the content. Abstraction networks may have different levels of granularity
even when they cover the same area of the terminology.
In addition to the SN, abstraction networks for the UMLS
include a metaschema [25], Semantic Groups [26], and
the Refined Semantic Network [24].
Within the context of the UMLS, we find an extensive
treatment of chemical concepts. In that subdomain, there
are many concepts that are assigned more than one ST.
Indeed, the definition of the ST Chemical states:
“. . .Chemicals are viewed from two distinct perspectives
in the network, functionally and structurally. Almost every
chemical concept is assigned at least two types, generally
one from the structure hierarchy and at least one from the
function hierarchy.” (See http://semanticnetwork.nlm.nih.
gov/Download/RelationalFiles/SRDEF.) A disadvantage of
this is that it leads to the situation where the extent of a
given ST may contain concepts elaborating variegated
semantics. For example, one concept, say, C1 assigned the
ST X may simultaneously be assigned Y, while another C2
assigned X may be assigned Z at the same time. Thus, in
the extent of X, we find C1 which is an X and a Y, and C2
which is an X and a Z. This arrangement cannot be ascertained from the level of the SN, which degrades its utility
as an abstraction network because the organization of collections of concepts into groups that share the same ST
assignment results in groups of semantically inconsistent
concepts. Indeed, in [27] we observed that using the
current SN a conjugate chemical is not distinguished from
a complex chemical.
In this paper, we present a methodology for expanding
the portion of the SN focused on chemicals with additional types in order to acquire a finer-grained Chemical
Specialty Semantic Network (CSSN). The CSSN will comprise types that are in fact disjoint, meaning all concepts
will be assigned one and only one type. This arrangement
better supports user comprehension and auditing. The
derivation of a CSSN utilizes techniques previously developed for the Refined Semantic Network (RSN) [21,22],
which promotes multiple ST combinations to the level of
first-class types.
Let us emphasize that we are not necessarily proposing
to expand the SN itself, but are allowing portions of it to
be expanded according to users’ and applications’ needs. In
fact, the work completely leverages the existing SN framework and the current assignments of STs to concepts. That
is, any new type (called an intersection semantic type (IST))
appearing in a CSSN is derived strictly from existing STs
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based on the underlying assignment of those types to concepts in the META. No effort is spent on manually adding
new knowledge to the UMLS. The ISTs are named in
meaningful ways that express the type combinations.
Moreover, the user is given control of a threshold parameter governing the minimum number of concepts required
to be assigned an IST in order for it to qualify for inclusion
in a CSSN. Choosing this threshold parameter allows for
the creation of various CSSNs, each exhibiting a different
depth of display.
We demonstrate the novel use of a CSSN as an upperlevel compact semantic network for an ontology of chemicals, the Chemical Entities of Biological Interest (ChEBI)
[28], an ontology for biochemistry of the Open Biological
and Biomedical Ontologies (OBO) Foundry. For our demonstration, we describe our use of the CSSN to categorize
a random sample of ChEBI chemical compounds. The
categorization of these compounds into CSSN types has
potential application for mapping data sources—especially
if one of the sources is a UMLS source vocabulary. The
need for semantic models in chemistry is described in
[29]. The CSSN is an effort towards building a resource
with application to ontologies, terminology mapping, and
natural language processing.
The Refined Semantic Network (RSN) [21,22] was
introduced as a finer-grained UMLS categorization network that exhibits so-called semantically uniform type
extents. To distinguish between the STs of the SN and
the types of the RSN we call the RSN types refined semantic types (RSTs). These RSTs, derived from the SN
and the META, consist of two kinds: pure semantic types
(PSTs), each corresponding to a specific ST in the SN,
and intersection semantic types (ISTs). A PST assignment
is used for a concept that is assigned only one ST. For
example, Neuromuscular transmission drug (C0357560)
is assigned just Pharmacologic Substance and therefore
retains this assignment in the RSN with an assignment
to the PST of the same name.
The ISTs are reifications of combinations of multiple
ST-assignments. Specifically, if a concept C is assigned
two STs, say, A and B, then an IST appears in the RSN
representing the assignment of both A and B. This IST
is named A \ B, where “\” denotes set intersection. Instead of assigning C both A and B, it is assigned only
the type A \ B. For example, Baclofenc (C0004609) is
assigned both Amino Acid, Peptide, or Protein and
Pharmacologic Substance. Therefore, in the RSN it is
assigned only the IST Amino Acid, Peptide, or Protein
\ Pharmacologic Substance.
The construction of ISTs via the combination of multiple STs depends on the existing assignment of STs to
concepts, following the UMLS’s practice of postcoordination for type assignment. Overall, the extents of
the RSTs are disjoint and form a partition of the META.
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The concepts in the extent of a particular type in the
RSN all share the same original ST assignments. Due to
this, we say the extents of the RSTs are semantically uniform, a property that is not true for the extents of the
STs. For example, all the concepts assigned exactly the
IST Pharmacologic Substance \ Lipid are lipids used
pharmacologically, while all the concepts assigned the
PST Lipid are just lipids. In contrast, the extent of the
ST Lipid from the SN is not semantically uniform since
some concepts are just lipids while others are also used
pharmacologically.
One application of the RSN has been in auditing the
UMLS. Our experience is that ISTs with small extents (six
or fewer concepts) often contain concepts with erroneous
ST assignments [21,22,27,30]. For example, in a sample of
59 chemical concepts from ISTs assigned to just one concept, 20 were found to have incorrect ST assignments
[30]. As an illustration, the concept Metaltite (C1700474)
was the only one in the UMLS 2006AB assigned both Nucleic Acid, Nucleoside, or Nucleotide and Biomedical
or Dental Material. Upon analysis, it was found that this
concept represents MetaltiteW, a primer used to improve
adhesion between resins and precious metals. The assignment of Nucleic Acid, Nucleoside, or Nucleotide was
thus in error. The NLM corrected this in the UMLS
2007AB by changing the ST assignment to Organic
Chemical. As a result of correcting such ST assignments,
the corresponding 20 chemical ISTs disappeared from the
RSN. In another audit sample of ten chemical ISTs
assigned to just two chemical concepts each, 16 of the 20
concepts were found to have ST assignment errors, and
nine of these ten chemical ISTs were slated for removal
[27]. More recently, we have reviewed concepts of chemical intersections with six or fewer concepts in the UMLS
2009AB and found that 73 of the existing 151 ISTs only
exist because of current inconsistent ST assignments given
the concepts of their extents. As these inconsistencies are
resolved by the UMLS editors, these 73 small ISTs are
expected to disappear from future versions of the RSN.
Our CSSN can be used in the same way as the RSN to determine partitions of concepts in the META that merit the
review of an auditor by choosing a threshold value of one
and selecting ISTs of extents of up to six concepts [30,31].
The ChEBI ontology is used by a variety of computer
systems and projects for tasks such as cataloging chemical transformations [32], identification of small molecules by matching electron ionization-mass spectra [33],
and the development of a chemical dictionary for text
mining [34]. The ChEBI is independent of the UMLS in
organization, structure, and source data.

Experimental
In this section, we first describe the derivation of the types
for a Chemical Specialty Semantic Network (CSSN) from
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the RSN, followed by a description of the use of the
threshold value to exclude certain types. After that, we
present our means for dealing with type assignment for
concepts whose original types have gone away. Naming
conventions are then presented for the types of a CSSN,
and the details of its hierarchical configuration are given.
Finally, our application of a CSSN to ChEBI is described.
Deriving the types of the chemical specialty semantic
network

The Chemical Specialty Semantic Network (CSSN) was
extracted from the RSN in the following manner. The
CSSN included every RST in the RSN that was derived
from Chemical or one of its descendants. We will call
this group of RSTs the Chemical RSTs. According to the
definition of the RSN, this implies that for any combination of several Chemical STs for which there were concepts assigned exactly to this combination, there existed
an IST that was potentially included in the CSSN. For
example, because in the META there were 490 concepts
assigned exactly Amino Acid, Peptide, or Protein and
Antibiotic, the CSSN included an IST Amino, Acid,
Peptide, or Protein \ Antibiotic. Out of the 381 total
ISTs in the RSN for the UMLS 2009AA release, 348 consisted of combinations of STs in which at least one ST
was in the subtree of Chemical.
As noted, multiple ST-assignments naturally occurred
for the STs in the subtree rooted at Chemical due to the
typical combination of structural and functional dimensions mentioned in its definition. For example, the extent
of IST Organic Chemical \ Pharmacologic Substance
had 76,832 concepts. Furthermore, many chemical substances displayed multiple functional aspects, including
the 1,940 concepts that were assigned Amino Acid, Peptide, or Protein \ Pharmacologic Substance \ Immunologic Factor. Among the 100 ISTs with the largest
extents in the UMLS 2009AA, only eight did not pertain
to chemicals.
In this study we used the intersection semantic types
which we introduced in our previous research [22] about
the RSN. However, we realized that the large number of
the refined semantic types in the RSN is preventing the
use of intersection semantic types as first-class types. By
concentrating this study on the chemical concepts in the
META and the chemical semantic types, the emerging
CSSN abstraction network is of a smaller magnitude
which will enable its adoption in a practical way for the
chemical research community, by providing a more
refined categorization. Another advantage is that the
extents of the types of the CSSN provide semantically
uniform categorization of all concepts, which is not true
for the SN.
The few concepts with ST assignments to both chemical and non-chemical STs were included when
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materializing the CSSN by only taking into account the
chemical STs. The non-chemical STs were ignored. For
example, the concept Soap (C0037392) was assigned two
STs in the META, one a chemical and one a nonchemical. For the CSSN, we consider Soap a chemical
with the ST Lipid and ignore the fact that in the META
it is also assigned the non-chemical type Manufactured
Object. The largest two groups of such concepts are
combinations of ST Food with a chemical ST of Carbohydrate or Lipid, such as Dietary Sucrose (C0376597),
and Nut Oil (C1518477).

Methods
Use of a threshold value to determine inclusion of an
intersection semantic type

The extent of a given IST can be quite small, in fact, as
small as one concept. It may be argued that a collection of
concepts of a small size should not qualify as a type unto
itself since a type is a broad category. To address this
issue, we allowed for the specification of a threshold value
N on IST extent sizes for qualification as a type. If an IST’s
extent size was below N, then it was omitted from the
CSSN. As a consequence, some chemical concepts in the
META lost IST-coverage. (This will be discussed further
in Section Type Coverage for Concepts in ISTs Falling
Below the Threshold Value.) Varying N enabled the generation of a CSSN tailored to the needs of a specific application. It should be kept in mind that the choice of N is a
tradeoff between the CSSN’s size and the percentage of
concepts it covers. For the purpose of auditing, a value of
N = 1 would certainly be warranted as many errors occur
in concepts assigned ISTs that have very small extents
[21,22,27,30,31].
Type coverage for concepts in ISTs falling below the
threshold value

When a threshold value N > 1 is used to generate a CSSN,
there will be some concepts that lose IST-coverage. This
may be an acceptable tradeoff for some applications. However, for applications in which the loss of type coverage of
concepts is unacceptable, the best solution is to assign the
concept the IST that has the most closely related semantics. This can be taken to be the more general or “ancestor” types of the IST that is being dropped. For example,
the concept Adrenal cortex agent (C1445697) was the only
concept in the UMLS 2009AA that was assigned exactly
the three STs Organic Chemical, Hormone, and Immunologic Factor. Consequently, when N > 1, the IST
Organic Chemical \ Hormone \ Immunologic Factor
did not appear in the resulting CSSN. However, the two
ancestor ISTs Organic Chemical \ Hormone and Organic Chemical \ Immunologic Factor existed in the
CSSN with extent sizes of 62 and 136, respectively. Either
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of these ISTs provided better coverage for Adrenal cortex
agent than any other type in the CSSN.
We proposed two approaches to resolve this issue. In
the first, we simply added the concept to the IST with the
larger extent size. For example, Adrenal cortex agent
should be assigned the Organic Chemical \ Immunologic Factor because it has a larger extent size than the
other possibility, Organic Chemical \ Hormone.
In the second approach, we gradually relaxed the specificity of types to determine a more general IST. This relaxation is applicable to ISTs derived from either multiple
functional STs or multiple structural STs. Relaxation can
also be applied to ISTs that represent both multiple functional and multiple structural STs. A natural grouping of
chemical STs exists among types that describe structure.
Another natural grouping exists among chemical semantic
types that describe function. By first separating types into
structural groups and functional groups and then gradually relaxing types in a group into ancestor types, the IST
which maintains the most specificity available may be
determined. For example, the abovementioned Adrenal
cortex agent had two functional ST assignments, Hormone and Immunologic Factor, that shared the common
parent Biologically Active Substance. Therefore, these
two more specific functional STs could be relaxed into
Biologically Active Substance. The single structural assignment to Organic Chemical is retained. Using this approach, the concept Adrenal cortex agent was assigned
Organic Chemical \ Biologically Active Substance,
which had an extent size of 4,151 concepts in the UMLS
2009AA.
We also demonstrate this approach in a second example
using a higher threshold value and an IST with a larger extent size. Using N = 500, the IST Organic Chemical \
Pharmacologic Substance \ Immunologic Factor,
which had an extent of only 249 concepts, was excluded
from the CSSN. The only structural type of this IST was
Organic Chemical. The type Chemical Viewed Functionally was the common ancestor of the two functional
types, Pharmacologic Substance and Immunologic Factor. However, the relaxation of the types started with Immunologic Factor because it can be relaxed without
going directly to the common ancestor. Immunologic
Factor was relaxed to its parent type, Biologically Active
Substance. The IST Organic Chemical \ Pharmacologic Substance \ Biologically Active Substance had an
extent size of 507 and was therefore a valid IST in a CSSN
with N = 500. As such, the 249 concepts assigned each of
the STs Organic Chemical, Pharmacologic Substance,
and Immunologic Factor were assigned the IST Organic
Chemical \ Pharmacologic Substance \ Biologically
Active Substance in a CSSN generated using this
approach.
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Type names in the CSSN

CSSN as an upper-level abstraction network for ChEBI

While theoretically accurate, names of ISTs like “A \ B”
can be cumbersome and unnatural to a user. For this
reason, we went through the process of renaming them
with an eye toward syntactical consistency, in the same
vein as for term-name construction [35]. In general,
an IST name is a concatenated list of words drawn
from its STs’ names, dropping unessential words
(e.g., “substance” or “chemical”). We prioritized, by
putting to the right, more specific functional aspects
over structural aspects and, in turn, prioritized those
over more general-purpose functional aspects. For
example, Pharmacologic Steroid is first and foremost a steroid. Example names are presented in
Section Hierarchical structure of the CSSN and in
Additional file 1: Table S1.

As a proof of concept, we applied a CSSN as an upperlevel abstraction network for ChEBI in the same capacity
that the SN is used for the META. Such support could
be useful for mapping between the ChEBI and the
UMLS source vocabularies. As a matter of fact, for those
ChEBI compounds that also appeared in the UMLS,
their type-assignment with respect to the CSSN was
deduced automatically from their UMLS ST assignments. A random sample of ChEBI compounds was
selected from version 1.50 of ChEBI.

Hierarchical structure of the CSSN

As with the RSN, a CSSN’s hierarchical structure was a
directed acyclic graph rather than a tree. The derivation
of its IS-As followed those of the RSN. Each PST had an
IS-A relationship identical to that of its corresponding
ST in the SN. On the other hand, the IS-As of an IST
were derived. In fact, an IST must always have at least
two parents. While it is theoretically possible that an
IST could be induced by a total of four or more ST
assignments, most were with respect to two or three.
We denote such an IST as a 2-IST or 3-IST, respectively.
Let us consider the IS-As of 2-ISTs and 3-ISTs. First,
each 2-IST had two IS-As, one to each of the PSTs corresponding to the STs from which it was derived. As an
illustration, Pharmacologic Organic Chemical had one
IS-A to Organic Chemical and another to Pharmacologic Substance.
A 3-IST may have one of the four possible IS-A configurations illustrated in Figure 1. Arrows in the figure
represent IS-As, and boxes represent types. Configuration (A) shows the largest 3-IST Pharmacologic Immunologic Amino Acid, Peptide, or Protein (with an
extent of 2,087 concepts) having exactly three IS-As to
the 2-ISTs Pharmacologic Immunologic Factor,
Pharmacologic Amino Acid Peptide or Protein, and
Immunologic Amino Acid Peptide or Protein. Configuration (B) shows the 3-IST Pharmacologic Hazardous
or Poisonous Organic Chemical with a pair of IS-As to
the 2-ISTs Hazardous or Poisonous Organic Chemical
and Pharmacologic Organic Chemical. Configuration
(C) shows the 3-IST Pharmacologic Steroid Hormone
linked to the 2-IST Pharmacologic Steroid and the PST
Hormone. Configuration (D) is theoretically possible
but not actually found in the RSN derived from the
UMLS 2009AA. We include it here for the sake of completeness. In that configuration, there are exactly three
IS-A relationships, each directed to a PST.

Results and discussion
CSSN

A total of 53 concepts with ST assignments to both a
chemical and a non-chemical ST were included in our
analysis by ignoring the non-chemical ST assignment
and only taking into account the assignment to the
chemical ST. Examples of such concepts (Soap, Dietary
Sucrose, Nut Oil, etc.) are described at the end of
Section "Deriving the types of the chemical specialty semantic network. A CSSN was generated for a threshold
value of N = 300, which again is applicable only to ISTs,
not PSTs. This CSSN had a total of 68 types: 25 PSTs
(some having less than 300 concepts) and 43 ISTs (with
a minimum of 300 concepts). Table 1 shows a partial
listing of this CSSN. The first column lists the RST. The
second column shows the number of concepts in its extent. The third column shows the new name of the type,
with appropriate hierarchical indentation utilized. PSTs
appear without an asterisk. An IST is listed indented
under one of its parents; 2-ISTs are preceded by one asterisk, and 3-ISTs are preceded by two asterisks. Each
asterisk indicates the presence of another parent. For example, Amino Acid, Peptide, or Protein \ Immunologic Factor had 12,662 concepts in its extent and was
renamed Immunologic Amino Acid, Peptide, or Protein. As noted, a 3-IST may be a child of a 2-IST. To resolve the display of the two or three parents for an IST,
we located it (indented) directly under the parent ST (or
2-IST) with the higher priority, which according to our
naming convention is the rightmost part in the IST’s
name. For a 2-IST, denoted by “*,” the other parent can
be easily identified by the leftmost word in the IST’s
name. The complete listing of this CSSN can be found
in Additional file 1: Table S1. A total of 62.6% (220,451
of 352,129) concepts were assigned to ISTs in the CSSN.
Table 2 shows the effect of changing the threshold
value. The first column contains the threshold value (N).
The second column shows the quantity of types that
existed for a CSSN derived using the threshold value
from the first column. The third column of the table
shows the percentage of concepts in the META that are
covered by the types available in a CSSN that is derived
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Figure 1 Four possible IS-A configurations for a 3-IST.

using the threshold value from the first column. The
row with a threshold value of 300 is shaded to
emphasize that the results reported in this study refer to
a CSSN derived using a threshold value of 300.
There are 352,129 concepts with a chemical ST assignment in the META. Table 3 lists the chemical types in
the first column. The second column shows the number
of concepts with that ST assignment using the SN. Concepts with multiple ST assignments are counted more
than once in the second column, once for each chemical
ST assigned. The first column also corresponds to the
PSTs of the CSSN. The third column shows the number
of concepts assigned each PST, which are counted only
once in the CSSN.
ChEBI categorization

We randomly selected 200 compounds from the list of
34,055 parent compounds with names (we did not use
any unnamed compounds). Of the 200 ChEBI compounds

selected for examination, 42 were found in the META by
manual review using both lexical and semantic matching,
and their existing ST assignments were used to derive
their type assignments in the CSSN. For example, the
ChEBI compound 1,1-dimethylhydrazine corresponded to
the UMLS concept dimazine (C0058187), which was
assigned Organic Chemical. For the 151 ChEBI compounds for which synonymous concepts were not found
in the META, a type assignment from the CSSN was given
by one of the authors (LC), a biochemist, after reviewing
the literature cited in ChEBI. Overall, 143 compounds
were assigned PSTs and 49 were assigned ISTs. Only eight
of the 200 compounds did not have coverage of their
assigned type using the CSSN we generated. Table 4
shows the number of ChEBI compounds from the sample
of 200 that we assigned to each PST or IST. Shaded rows
mark ISTs of the eight compounds that do not have coverage in our CSSN because their extent size for the META
is below our threshold value of 300. The percentage of
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Table 1 Partial listing of the CSSN with threshold value of 300
RST
Chemical
Chemical Viewed Structurally

# Concepts

Name in CSSN (hierarchically indented)

26

Chemical

248

Chemical Viewed Structurally

Organic Chemical

58,347

Organic Chemical

Amino Acid, Peptide,
or Protein

16,973

Amino Acid, Peptide,
or Protein \ Immunologic Factor

12,662

*Immunologic Amino Acid, Peptide, or Protein

Amino Acid, Peptide,
or Protein \ Pharmacologic Substance

6,537

*Pharmacologic Amino Acid, Peptide, or Protein

Amino Acid, Peptide,
or Protein \ Pharmacologic
Substance \ Immunologic Factor

1,940

**Pharmacologic Immunologic Amino Acid,
Peptide, or Protein

Amino Acid, Peptide, or Protein

. . .and many more. . .
Chemical Viewed Functionally

174

Biologically Active Substance

1,026

Immunologic Factor

7,181

Pharmacologic Substance
\ Immunologic Factor

1,065

Chemical Viewed Functionally
Biologically Active Substance
Immunologic Factor
*Pharmacologic Immunologic
Factor

. . .and many more. . .

coverage of the ChEBI compounds is 96.0% (192 of 200)
which is very close to the 97.3% coverage of META concepts that was achieved with CSSN of the same threshold
value. For the ChEBI compounds lacking a type assignment in the CSSN it would be necessary to employ one of
the relaxation approaches we described in Section Type
coverage for concepts in ISTs falling below the threshold
value.
The CSSN (e.g., with N = 300) promotes common
combinations of chemical ST assignments to the level of
types. This is expressed by naming them according to
the combination semantics they elaborate. Our previous
work in auditing the UMLS shows that concepts
assigned ISTs with extents of six or fewer concepts tend
to indicate inconsistent ST assignments [21,22,27,30,31].
Over time, the correction of these inconsistent assignments in the UMLS will reduce the number of ISTs with
extents below the threshold value in a derived CSSN. In
turn, this will raise the percentage of coverage for the
various thresholds: the corresponding concepts will
move to other, potentially larger, ISTs.
A UMLS chemical concept drawn from several source
vocabularies may very well be assigned various STs by
different UMLS editors—not necessarily at the same
time. A CSSN can be seen as a form of pre-coordinated
guide for ST assignments to new chemical concepts—
with the caveat that the CSSN is “bootstrapped” from
the existing ST assignments—which were postcoordinated. In this capacity, it can streamline the type
assignment process and help prevent errors (such as the

inconsistent ST assignments that we have previously
reported on [21,22,27,30,31]). For example, with a CSSN,
a chemical concept must be assigned exactly one existing IST, taking into account the type’s semantic combination defined by its constituent STs. The new concept
can be compared to the concepts in the extent of the
proposed IST to confirm that they are semantically similar and should be grouped together.
There are times when the creation of a new IST is
warranted. For example, new chemical concepts that increase the coverage of the META or offer finer granularity may be justifications. In such cases, the newly added
concepts elaborate semantics that were not previously in
the UMLS and are more accurately represented with a
new IST. Therefore, the new IST can be allowed, for a
time, even though its extent size is below the threshold
value. After ST assignments are made, it will be seen
whether the extent of the new IST has grown enough to
validate its existence. If not, those concepts that were
temporarily assigned it would be automatically reTable 2 Effects of varying the threshold value
Threshold
value, N

Number of types
in CSSN

500

Percentage of coverage of
concepts in META

52

95.3%

300

68

97.3%

100

102

98.9%

50

123

99.4%

1

373

100.0%
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Table 3 Comparison of type assignments in SN and type
assignments of PSTs in the CSSN
Type name (ST in SN or
PST in CSSN)
Chemical
Chemical
Viewed Structurally
Organic Chemical
Steroid

# of concepts
assigned in SN

# of concepts
assigned in CSSN
26

26

385

248

154,400

58,347

10,205

4,883

Eicosanoid

1,200

537

Nucleic Acid, Nucleoside,
or Nucleotide

9,172

4,727

Organophosphorus
Compound

2,401

Amino Acid, Peptide,
or Protein
Carbohydrate
Lipid
Chemical
Viewed Functionally
Pharmacologic Substance
Biomedical or
Dental Material
Biologically
Active Substance
Neuroreactive Substance
or Biogenic Amine

of STs to new concepts if the ChEBI were to be integrated into the UMLS.
The main advantage of categorizing the compounds of
ChEBI with CSSN types rather than with SN types is a
more accurate categorization. For example, if assigned
SN types we see five of the 200 ChEBI compounds
reviewed would be assigned the ST Carbohydrate and
ten would be assigned the ST Lipid. However, using the

Table 4 CSSN types assigned to ChEBI sample compunds
Pure Semantic Type or Intersection Semantic Type

116,022

919
16,973

10,475

6,077

6,367

3,494

180

174

122,187

14,168

4,943

3,408

Amino Acid, Peptide, or Protein

9

Carbohydrate

3

Chemical Viewed Structurally

9

Eicosanoid

1

Element, Ion, or Isotope

6

Inorganic Chemical

9

Lipid

8

Neuroreactive Substance or Biogenic Amine

1

Nucleic Acid, Nucleoside, or Nucleotide
Organic Chemical

55,049

1,026

# Compounds

6
84

Organophosphorus Compound

4

Steroid

2

705

20

Biologically Active Amino Acid, Peptide, or Protein

2

2,973

147

Amino Acid, Peptide, or Protein Enzyme

1

Enzyme

25,526

233

2,357

117

Indicator, Reagent, or Diagnostic Aid Amino Acid,
Peptide, or Protein

1

Vitamin
Immunologic Factor

24,305

7,181

Neuroreactive or Biogenic Amine Amino Acid,
Peptide, or Protein

1

Indicator, Reagent,
or Diagnostic Aid

12,803

4,350

Inorganic Biomedical or Dental Material

1

Hazardous
or Poisonous Substance

5,750

422

Carbohydrate Lipid

2

Pharmacologic Inorganic Chemical

2

Receptor

4,417

125

4,554

546

Nucleic Acid, Nucleoside, or Nucleotide
Amino Acid, Peptide, or Protein

1

Antibiotic
Element, Ion,
or Isotope

1,800

1,004

Biologically Active Nucleic Acid,
Nucleoside, or Nucleotide

1

Inorganic
Chemical

5,762

2,490

Nucleic Acid, Nucleoside, or Nucleotide
Carbohydrate

1

Organic Antibiotic

7

Biologically Active Organic Chemical

6

Hormone

assigned an existing IST using one of the techniques
described in Section Type coverage for concepts in ISTs
falling below the threshold value.
The initial study with the sample of 200 ChEBI compounds showed the feasibility of using a CSSN as an
upper-level network for ChEBI. Of course, more studies
are necessary to evaluate the effort required for assigning PSTs and ISTs to all ChEBI compounds. The CSSN
type assignments would greatly facilitate the assignment

Hazardous or Poisonous Organic Chemical

4

Organic Indicator, Reagent,
or Diagnostic Aid

2

Pharmacologic Organic Chemical

20

Pharmacologic Organic Hormone

1

Organic Vitamin

1

Organophosphorus Indicator, Reagent, or
Diagnostic Aid

1

Hazardous or Poisonous Inorganic Chemical

1
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CSSN types for categorization, two compounds, alphaD-galactosyl undecaprenyl diphosphate and galactosylceramide sulfates, are assigned IST Carbohydrate Lipid,
three are just PST Carbohydrate, and eight are just PST
Lipid. This is a more refined categorization, which also
avoids repeated counting of the same concept due to its
multiple ST assignments. Similarly, there are 12 compounds in the sample that would be assigned ST Inorganic Chemical. But using CSSN categories we see that
three of the 12 also have a functional perspective given.
With the functional perspective the three ISTs Inorganic Biomedical or Dental Material, Pharmacologic
Inorganic Chemical, and Hazardous or Poisonous Inorganic Chemical are each assigned a compound, while
the remaining nine are purely categorized with the Inorganic Chemical type (see Table 4), thereby maintaining
the semantic uniformity of the type categorizations.
There is an inherent conflict between detailed coverage of various areas in biomedicine and the need for a
compact semantic network that effectively abstracts it.
For applications in specific areas such as genomics, anatomy, chemistry, zoology, physiology, pharmacology, and
pathology, there is a need for more detailed categories
(types). However, if all such categories were added to the
SN, its size would be an order of magnitude higher, and
it would lose some of its effectiveness. A possible solution would be to leave the SN with approximately the
same size and structurally modify it in other ways, such
as converting it into a directed acyclic graph from its
current two-tree configuration [23,24]. Alongside the
SN, specialty semantic networks for specific areas having
enhanced coverage within the appropriate subnetworks
could be derived. Those specialty abstraction networks
could grow to a size on the same order of magnitude as
the SN itself. In this way, effective compact coverage
could be achieved for various areas.
In this paper, we have described one methodology
based on existing ISTs from the RSN that is applicable
to chemicals—as we have demonstrated. Another field
where a specialty semantic network can be applicable is
for the semantic group of disorders [26,36] where there
are meaningfully large intersections. Examples of intersections with extents beyond 1,000 concepts for the disorder domain include: Anatomical Abnormality \
Disease or Syndrome, Congenital Abnormality \ Disease or Syndrome, and Neoplastic Process \ Experimental Model of Disease. For other fields, specialty
networks may be derived using other techniques. See,
e.g., suggested coverage for genomics [17] building on
earlier work in [19].
There exist other abstraction networks for chemistry
and life science, which are intended as ontologies that
support mapping and integration between the ontologies
in OBO. In [37], an upper-level ontology for Chemistry
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was created based on ChEBI. The foundational relations
of ChEBI were analyzed and rewritten to be compatible
with the OBO Relation Ontology (RO) [38]. The identified top-level classes of ChEBI were aligned with the
Basic Formal Ontology (BFO) types [39]. The other
upper domain ontology for the life sciences, BIOTOP
[40] was developed from the GENIA ontology [41]
(see http://www-tsujii.is.s.u-tokyo.ac.jp/GENIA/home/
wiki.cgi?page=GENIA+Ontology). However, in BIOTOP
the structure of the GENIA was redesigned to overcome the existing shortcomings. New classes and relation types were introduced into BIOTOP and some
classes of the GENIA were removed. The ontologies
in the OBO can be integrated by using BIOTOP as a
common top level ontology.
Compared to the above described abstract networks,
the CSSN can be automatically generated from the
UMLS Semantic Network and Metathesaurus. It is better suited for mapping between ChEBI and UMLS
source vocabularies. For 200 sample compounds of
ChEBI, 96% of were associated with semantic types in
the CSSN. According to the results for this sample, it
seems that this level of coverage applies for the whole
ChEBI.
Both the upper-level ontology for chemistry and BIOTOP include categories such as “Atom” and “Molecule”
which are intended for use as top-level ontologies that
connect domain ontologies to BFO or as a bridge to integrate different ontologies of OBO. In contrast, the
CSSN provides an abstraction network with categories
such as “Organic Chemical” and “Hazardous or Poisonous Organic Chemical”, which fit for mapping the ChEBI
ontology to UMLS source vocabularies.

Conclusion
We have presented a methodology for deriving a specialty semantic network for the chemical domain directly
from the existing UMLS Semantic Network and
Metathesaurus, based on a threshold value that regulated the inclusion of new chemical types. Our CSSN
afforded a more refined categorization of the UMLS’s
chemical concepts. Such an approach can be repeated
for other subdomains of biomedicine such as disorders,
although in that domain there are fewer intersections of
STs. An important aspect of this work was the fact that
it was done without extending the SN itself into a network that is too large. We demonstrated that a CSSN
can be derived according to the needs of an application
as expressed by the threshold value. At the same time,
deriving such a network, rather than building it from
scratch, has the benefit of leveraging the wealth of
knowledge accumulated in the UMLS over the years.
Among the benefits of a CSSN is the potential for
serving as an upper-level semantic network for an
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ontology of chemicals such as OBO’s ChEBI, providing
the chemical ontology with a network playing the same
role that the SN does for the META. A CSSN could be a
useful guide for the assignment of STs to new concepts
as they are added to the UMLS. Generation of a CSSN
using a low threshold value yields a useful tool for auditing the META. A CSSN could also be applied during the
mapping or alignment between a UMLS source vocabulary and another source of chemical concepts.

Endnotes
a
Additional file 2 contains a glossary of acronyms
used.
b
Semantic types are written in bold.
c
Concepts are written with the preferred term in italics
and the Concept Unique Identifier (CUI) following in
parenthesis.
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